{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT05136807",
            "orgStudyIdInfo": {
                "id": "2016-0172"
            },
            "secondaryIdInfos": [
                {
                    "id": "NCI-2021-11118",
                    "type": "REGISTRY",
                    "domain": "CTRP (Clinical Trial Reporting Program)"
                },
                {
                    "id": "2016-0172",
                    "type": "OTHER",
                    "domain": "M D Anderson Cancer Center"
                }
            ],
            "organization": {
                "fullName": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "briefTitle": "Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies",
            "officialTitle": "Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies",
            "therapeuticArea": [
                "Other"
            ],
            "study": "quality-of-life-in-patients-with-asymptomatic-monoclonal-gammopathies"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-05",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2016-06-07",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-02-02",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-02-02",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2021-11-11",
            "studyFirstSubmitQcDate": "2021-11-23",
            "studyFirstPostDateStruct": {
                "date": "2021-11-29",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-05-17",
            "lastUpdatePostDateStruct": {
                "date": "2024-05-20",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "M.D. Anderson Cancer Center",
                "class": "OTHER"
            },
            "collaborators": [
                {
                    "name": "National Cancer Institute (NCI)",
                    "class": "NIH"
                }
            ]
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "This study examines the quality of life in patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma. Collecting quality of life information from patients may help doctors learn more about the most common symptoms and concerns patients with monoclonal gammopathy of unknown significance and smoldering multiple myeloma may have.",
            "detailedDescription": "PRIMARY OBJECTIVE:\n\nI. Describe baseline and follow up quality of life and monoclonal gammopathy of unknown significance/smoldering multiple myeloma (MGUS/SMM) related anxiety of patients with MGUS/SMM already participating in clinical trials at MD Anderson Cancer Center.\n\nSECONDARY OBJECTIVE:\n\nI. Identify the most common symptoms/patients concerns to evaluate future interventions for treatment/prevention in this population.\n\nOUTLINE:\n\nPatients complete quality of life questionnaires over 10-15 minutes at baseline and every 6 months for patients participating in an observational study or every month for patients participating in a treatment study for up to 3 years."
        },
        "conditionsModule": {
            "conditions": [
                "Monoclonal Gammopathy of Undetermined Significance",
                "Smoldering Plasma Cell Myeloma"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "designInfo": {
                "observationalModel": "COHORT",
                "timePerspective": "PROSPECTIVE"
            },
            "enrollmentInfo": {
                "count": 400,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Observational (quality of life questionnaire)",
                    "description": "Patients complete quality of life questionnaires over 10-15 minutes at baseline and every 6 months for patients participating in an observational study or every month for patients participating in a treatment study for up to 3 years.",
                    "interventionNames": [
                        "Other: Quality-of-Life Assessment",
                        "Other: Questionnaire Administration"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "OTHER",
                    "name": "Quality-of-Life Assessment",
                    "description": "Complete questionnaires",
                    "armGroupLabels": [
                        "Observational (quality of life questionnaire)"
                    ],
                    "otherNames": [
                        "Quality of Life Assessment"
                    ]
                },
                {
                    "type": "OTHER",
                    "name": "Questionnaire Administration",
                    "description": "Complete questionnaires",
                    "armGroupLabels": [
                        "Observational (quality of life questionnaire)"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Quality of life questionnaires",
                    "description": "Patients complete quality of life questionnaires over 10-15 minutes at baseline.\n\nScore scale ranges from (1-4) 1 - Not at all and 4 - Almost all the time",
                    "timeFrame": "Up to 3 years"
                },
                {
                    "measure": "Quality of life questionnaires",
                    "description": "Patients complete quality of life questionnaires every 6 months for patients participating in an observational study or every month for patients participating in a treatment study for up to 3 years.\n\nScore scale ranges from (1-4) 1 - Not at all and 4 - Almost all the time",
                    "timeFrame": "Up to 3 years"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients with either monoclonal gammopathy of unknown significance age \\>= 18 years old.\n\n  * Both criteria must be met:\n\n    * Serum monoclonal protein \\< 3 g/dL or urinary monoclonal protein \\< 500 mg per 24 hours and clonal bone marrow plasma cells \\< 10%\n    * Absence of myeloma defining events or amyloidosis\n* OR Patients with smoldering multiple myeloma age \\>= 18 years old.\n\n  * Both criteria must be met:\n\n    * Serum monoclonal protein \\>= 3 g/dL or urinary monoclonal protein \\>= 500 mg per 24 hours and/or clonal bone marrow plasma cells 10-60%\n    * Absence of myeloma defining events or amyloidosis\n* Patients must be enrolled in clinical trials for SMM or MGUS at MD Anderson Cancer Center, including protocols PA15-0575 (NCT02726750) (Prospective observational study of clinical and genomic predictors of progression to myeloma in asymptomatic monoclonal gammopathies); 2015-0148 (Phase II single arm trial of Isatuximab in patients with intermediate and high risk smoldering multiple myeloma); and 2015-0371 (NCT02603887) (Pilot single arm, single center, open label trial of Pembrolizumab in patients with intermediate and high risk smoldering multiple myeloma) and any future clinical trials for MGUS and/or SMM that open at MD Anderson Cancer Center.\n* Only patients who are English or Spanish speaking are eligible.\n\nExclusion Criteria:\n\n* Evidence of myeloma defining events or biomarkers of malignancy due to underlying plasma cell proliferative disorder meeting at least one of the following\n\n  * Hypercalcemia: serum calcium \\> 0.25 mmol/L (\\> 1 mg/dL) higher than the upper limit of normal or \\> 2.75 mmol/L (\\> 11 mg/dL)\n  * Renal Insufficiency: creatinine clearance \\< 40 ml/min or serum creatinine \\> 2 mg/dL\n  * Anemia: hemoglobin value \\< 10 g/dL or 2 g/dL \\< normal reference\n  * Bone lesions: one or more osteolytic lesions on skeletal radiography, computerized tomography (CT) or 2-deoxy-2\\[F-18\\] fluoro-D-glucose positron emission tomography CT (PET-CT).\n  * Clonal bone marrow plasma cell percentage \\>= 60%\n  * Involved: uninvolved serum free light chain ratio \\>= 100 measured by Freelite assay (The Binding Site Group, Birmingham, United Kingdom \\[UK\\])\n  * \\>1 focal lesions on magnetic resonance imaging (MRI) studies, if the patient has an MRI done per eligibility criteria (each focal lesion must be 5 mm or more in size)\n* Plasma cell leukemia.\n* Presence of cognitive impairment or delirium as determined by the primary clinician.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Patients with monoclonal gammopathy of unknown significance or smoldering multiple myeloma at MD Anderson Cancer Center",
            "samplingMethod": "NON_PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Melody Becnel, MD",
                    "role": "CONTACT",
                    "phone": "832-206-9804",
                    "email": "mrbecnel@mdanderson.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Elisabet E Manasanch",
                    "affiliation": "M.D. Anderson Cancer Center",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "M D Anderson Cancer Center",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77030",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Mei Huang",
                            "role": "CONTACT",
                            "phone": "713-745-9901",
                            "email": "mhuang3@mdanderson.org"
                        },
                        {
                            "name": "Elisabet E. Manasanch",
                            "role": "PRINCIPAL_INVESTIGATOR"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "M D Anderson Cancer Center",
                    "url": "http://www.mdanderson.org"
                }
            ]
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000009101",
                    "term": "Multiple Myeloma"
                },
                {
                    "id": "D000054219",
                    "term": "Neoplasms, Plasma Cell"
                },
                {
                    "id": "D000075122",
                    "term": "Smoldering Multiple Myeloma"
                },
                {
                    "id": "D000010265",
                    "term": "Paraproteinemias"
                },
                {
                    "id": "D000008998",
                    "term": "Monoclonal Gammopathy of Undetermined Significance"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009370",
                    "term": "Neoplasms by Histologic Type"
                },
                {
                    "id": "D000009369",
                    "term": "Neoplasms"
                },
                {
                    "id": "D000020141",
                    "term": "Hemostatic Disorders"
                },
                {
                    "id": "D000014652",
                    "term": "Vascular Diseases"
                },
                {
                    "id": "D000002318",
                    "term": "Cardiovascular Diseases"
                },
                {
                    "id": "D000001796",
                    "term": "Blood Protein Disorders"
                },
                {
                    "id": "D000006402",
                    "term": "Hematologic Diseases"
                },
                {
                    "id": "D000006474",
                    "term": "Hemorrhagic Disorders"
                },
                {
                    "id": "D000008232",
                    "term": "Lymphoproliferative Disorders"
                },
                {
                    "id": "D000007160",
                    "term": "Immunoproliferative Disorders"
                },
                {
                    "id": "D000007154",
                    "term": "Immune System Diseases"
                },
                {
                    "id": "D000006942",
                    "term": "Hypergammaglobulinemia"
                },
                {
                    "id": "D000011230",
                    "term": "Precancerous Conditions"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12058",
                    "name": "Multiple Myeloma",
                    "asFound": "Plasma Cell Myeloma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M27588",
                    "name": "Neoplasms, Plasma Cell",
                    "asFound": "Plasma Cell Myeloma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M11962",
                    "name": "Monoclonal Gammopathy of Undetermined Significance",
                    "asFound": "Monoclonal Gammopathy of Undetermined Significance",
                    "relevance": "HIGH"
                },
                {
                    "id": "M1462",
                    "name": "Smoldering Multiple Myeloma",
                    "asFound": "Smoldering Plasma Cell Myeloma",
                    "relevance": "HIGH"
                },
                {
                    "id": "M13178",
                    "name": "Paraproteinemias",
                    "asFound": "Monoclonal Gammopathy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12315",
                    "name": "Neoplasms by Histologic Type",
                    "relevance": "LOW"
                },
                {
                    "id": "M21977",
                    "name": "Hemostatic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M5059",
                    "name": "Blood Coagulation Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M17400",
                    "name": "Vascular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M5077",
                    "name": "Blood Protein Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M9490",
                    "name": "Hematologic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9560",
                    "name": "Hemorrhagic Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M11225",
                    "name": "Lymphoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10206",
                    "name": "Immunoproliferative Disorders",
                    "relevance": "LOW"
                },
                {
                    "id": "M10200",
                    "name": "Immune System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M9993",
                    "name": "Hypergammaglobulinemia",
                    "relevance": "LOW"
                },
                {
                    "id": "M14111",
                    "name": "Precancerous Conditions",
                    "relevance": "LOW"
                },
                {
                    "id": "T6034",
                    "name": "Quality of Life",
                    "asFound": "Quality of Life",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3947",
                    "name": "Multiple Myeloma",
                    "asFound": "Plasma Cell Myeloma",
                    "relevance": "HIGH"
                },
                {
                    "id": "T3867",
                    "name": "Monoclonal Gammopathy of Undetermined Significance",
                    "asFound": "Monoclonal Gammopathy of Undetermined Significance",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC04",
                    "name": "Neoplasms"
                },
                {
                    "abbrev": "BC14",
                    "name": "Heart and Blood Diseases"
                },
                {
                    "abbrev": "BC15",
                    "name": "Blood and Lymph Conditions"
                },
                {
                    "abbrev": "BC20",
                    "name": "Immune System Diseases"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "BXM",
                    "name": "Behaviors and Mental Disorders"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}